Healthtech Investors & VC Firms in Asia-Pacific
838 firms in this list, with a median first check of $600K. 163 of them lead rounds. Generated from verified public data and updated continuously.
Sully Group
London
3 people
CARELA Holding GmbH
Hamburg
Elron Ventures
Tel AvivSeed–Series B$1M – $17M
2 people
EVC Ventures
MiamiPre-Seed–Seed
1 person
AAG Ventures
Mithera Capital
SeattleSeed–Late Stage
CentreGold Capital
FremontPre-Seed–Series B
1 person
Biomark Capital
GreenwichSeries A–Late Stage$5M – $10M
4 people
One Capital
Westlake VillageSeed–Growth
A. M. Pappas & Associates
DurhamPre-Seed–Series A
1 person
Bioscience Equity Partners
DubaiLate Stage
1 person
CC Trust Group AG
BaarGrowth–Late Stage
10 people
IdealityRoads
1 person
808 Ventures
ClaremontPre-Seed–Series B$635K
Capitalworks
JohannesburgGrowth–Late Stage
Ela Capital
TorontoPre-Seed–Growth
World Innovation Lab (WiL)
Palo AltoPre-Seed–Late Stage$5M – $30M
10x Genomics
Pleasanton
4 people
Metagrove Ventures
Rosehill, New South WalesPre-Seed–Seed
2 people
Noria Capital
LondonSeries A
2 people
Chandaria Capital
NairobiPre-Seed–Growth
Believe
JeddahSeries B
Related lists
Investors & VC Firms in North America (13013)Investors & VC Firms in United States (12149)Investors & VC Firms in Europe (5511)Crypto & Web3 Investors & VC Firms (4820)Investors & VC Firms in Global (4182)SaaS Investors & VC Firms (3878)AI & Machine Learning Investors & VC Firms (3817)Fintech Investors & VC Firms (3738)Investors & VC Firms in Asia-Pacific (3570)Healthtech Investors & VC Firms (3445)
Data sourced from public filings and firms' own websites — see our methodology.
















